Literature DB >> 7766743

Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen.

N Hudson1, W G Brydon, M A Eastwood, A Ferguson, K R Palmer.   

Abstract

BACKGROUND: The optimum regimen for the eradication of Helicobacter pylori remains unclear. The aim of this study was to determine the efficacy and tolerability of omeprazole 40 mg daily given for 2 weeks, plus amoxycillin 500 mg t.d.s. and metronidazole 400 mg t.d.s. given for the first 7 days, in the treatment of H. pylori associated peptic ulcer disease.
RESULTS: One hundred and thirty-two consecutive patients with peptic ulcer disease were entered into the study (89 male, 41 female; median age 47 years; inter-quartile range: 36-58 years). H. pylori was eradicated successfully in 109 of 130 patients (intention-to-treat: 83%; 95% confidence limits: 76-89%); per protocol: 85% (95% CI: 78-91%)). Ninety per cent of patients completed the full course of therapy. Only four patients (3%) stopped treatment as a result of side effects although these occurred in 41% of patients. One patient developed pseudomembranous colitis requiring hospital admission.
CONCLUSION: Omeprazole combined with one week of treatment of amoxycillin and metronidazole is an effective and well tolerated Helicobacter eradication regimen. Occasional severe side effects remain a risk, even when the duration of antibiotic exposure is reduced.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766743     DOI: 10.1111/j.1365-2036.1995.tb00350.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

1.  A case of severe pseudomembranous colitis diagnosed by colonoscopy after Helicobacter pylori eradication.

Authors:  Satoshi Sato; Daisuke Chinda; Kiyonori Yamai; Ryu Satake; Yasushi Soma; Tadashi Shimoyama; Shinsaku Fukuda
Journal:  Clin J Gastroenterol       Date:  2014-05-08

2.  The cost effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden.

Authors:  P Unge; B Jönsson; N O Stålhammar
Journal:  Pharmacoeconomics       Date:  1995-11       Impact factor: 4.981

3.  [Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].

Authors:  J Glaser; J Hein; R Daikeler; G Weithofer; M Vieth; M Schmidt; M Stolte
Journal:  Med Klin (Munich)       Date:  1998-02-15

4.  Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis.

Authors:  A Kokkola; H Rautelin; P Puolakkainen; P Sipponen; M Färkkilä; R Haapiainen; T U Kosunen
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

5.  Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China.

Authors:  Chun-Hua Wang; Sheng-Tao Liao; Jun Yang; Chun-Xia Li; Ying-Ying Yang; Ran Han; Dong-Feng Chen; Chun-Hui Lan
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.